You are here

Article Text

Article menu

Download PDFPDF

XML
Editorial
Chronic kidney disease and the global NCDs agenda
  1. Brendon Lange Neuen1,2,
  2. Steven James Chadban1,3,
  3. Alessandro Rhyl Demaio4,
  4. David Wayne Johnson5,6,7,
  5. Vlado Perkovic2,8
  1. 1 Department of Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia
  2. 2 Renal and Metabolic Division, George Institute for Global Health, Sydney, Australia
  3. 3 Charles Perkins Centre, University of Sydney, Sydney, Australia
  4. 4 World Health Organization, Geneva, Switzerland
  5. 5 Centre for Kidney Disease Research, University of Queensland, Brisbane, Australia
  6. 6 Department of Nephrology, Princess Alexandra Hospital, Brisbane, Australia
  7. 7 Translational Research Institute, Brisbane, Australia
  8. 8 Department of Renal Medicine, Royal North Shore Hospital, Sydney, Australia
  1. Correspondence to Dr Brendon Lange Neuen; brendon.neuen{at}sswahs.nsw.gov.au

https://doi.org/10.1136/bmjgh-2017-000380

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    2017 is an important year for the international nephrology community. March 9 was World Kidney Day, the theme this year being ‘Kidney disease and obesity: healthy lifestyles for healthy kidneys’, highlighting the crucial link between the kidneys and metabolic and cardiovascular health. In April, the Global Kidney Health Atlas, one of the largest health-related country capacity reviews in history, was launched at the World Congress of Nephrology in Mexico City. The Atlas, a first for the nephrology community, is a multinational cross-sectional survey designed to assess need and capacity for kidney care worldwide and provide the foundation for a global surveillance network for chronic kidney disease (CKD) care.

    CKD is an enormous public health issue, the tide of which continues to inexorably rise. In the 2015 Global Burden of Disease Study, kidney disease was the 12th most common cause of death, accounting for 1.1 million deaths worldwide.1 Overall CKD mortality has increased by 31.7% over the last 10 years, making it one of the fastest rising major causes of death, alongside diabetes and dementia.1 In the same study, CKD ranked as the 17th leading cause of global years lost of life, an 18.4% increase since 2005, and the third largest increase of any major cause of death.1 This is in stark contrast to other non-communicable diseases, for example cardiovascular disease and chronic obstructive pulmonary disease, where global years lost of life fell during the same time period (−10.2% and −3.0%, respectively).1

    Unabated growth in the incidence of diabetic kidney disease, underpinned by a global imbalance between overnutrition and inadequate physical inactivity causing overweight and obesity, is the key driver of CKD burden. Between 2005 and 2015, the prevalence of diabetic kidney disease increased by 39.5% globally.1 In Mexico, the country with the highest CKD death rate in the world, …

    View Full Text